Relationship between A2A adenosine receptor expression and intradialytic hypotension during hemodialysis

被引:7
作者
Giaime, Philippe
Carrega, Louis
Fenouillet, Emmanuel
Mercier, Laurence
Gerolami, Victoria
Ruf, Jean
Sauze, Nicole
Brunet, Philippe
Saadjian, Alain
Berland, Yvon
Dussol, Bertrand
Guieu, Regis
机构
[1] Hop Conception, Serv Nephrol & Hemodialyse, Marseille, France
[2] Univ Mediterranee, CNRS, FRE 2738, Lab Ingn Prot, Marseille, France
[3] Lab Biochim & Biol Mol, Marseille, France
[4] INSERM, UMR 555, Fac Med, F-13258 Marseille, France
[5] Hop Nord Marseille, Serv Cardiol, Marseille, France
[6] Univ Mediterranee, Dept Nephrol, Marseille, France
[7] Hop St Marguerite, Ctr Invest Clin, Marseille, France
关键词
adenosine; A(2A) receptor; intradialytic hypotension;
D O I
10.2310/6650.2006.06005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Intradialytic hypotension (IDH) is a common complication of hemodialysis sessions (HDSs). Adenosine may contribute to the drop in blood pressure during IDH events because it has hypotensive effects. As A(2A) adenosine receptor expression is essential for blood pressure control, we compared the expression of A2A receptors (Bmax, K-D, and messenger ribonucleic acid [mRNA] levels) in peripheral blood mononuclear cells from IDH and non-IDH patients and from controls. We also evaluated adenosine plasma levels (APLs). Methods: We included 10 hemodialyzed patients with at least three IDH events per month. We also included 11 hemodialyzed patients with no history of IDH events and 10 healthy subjects as controls. Results: IDH patients had higher Bmax values than non-IDH patients (mean before HDS, +86%; after HDS, +112%), whereas non-IDH patients had lower Bmax values than controls (mean -72%). KD values were not significantly different between patients and controls. The levels of mRNA increased significantly during HDS but without an increase in receptor expression on the cell membranes. APLs were higher in hemodialyzed patients than in controls. Conclusion: We found that A2A receptors are more expressed in IDH patients than in non-IDH patients, whereas APL was high in all patients. Both high APL and a relative increase in A(2A) receptor expression may favor IDH events.
引用
收藏
页码:473 / 477
页数:5
相关论文
共 32 条
  • [1] Role of adenosine in delayed preconditioning of myocardium
    Baxter, GF
    [J]. CARDIOVASCULAR RESEARCH, 2002, 55 (03) : 483 - 494
  • [2] MORBIDITY AND MORTALITY IN HEMODIALYSIS - THE ROLE OF SCHEDULES
    BERLAND, Y
    BRUNET, P
    [J]. ARTIFICIAL ORGANS, 1995, 19 (08) : 827 - 831
  • [3] Brunet P, 1996, NEPHROL DIAL TRANSPL, V11, P46
  • [4] Adenosine A2A agonist reduces paralysis after spinal cord ischemia:: Correlation with A2A receptor expression on motor neurons
    Cassada, DC
    Tribble, CG
    Long, SM
    Kaza, AK
    Linden, J
    Rieger, JM
    Rosin, D
    Kron, IL
    Kern, JA
    [J]. ANNALS OF THORACIC SURGERY, 2002, 74 (03) : 846 - 849
  • [5] Pathophysiology of dialysis hypotension: An update
    Daugirdas, JT
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) : S11 - S17
  • [6] Kinetic study of adenosine concentrations and the expression of adenosine deaminase in mononuclear cells during hemodialysis
    Dussol, B
    Fenouillet, E
    Brunet, P
    Purgus, R
    Sauze, N
    Carrega, L
    Mercier, L
    Zouher, I
    Bechis, G
    Berland, Y
    Guieu, R
    [J]. KIDNEY INTERNATIONAL, 2004, 66 (04) : 1640 - 1646
  • [7] Parathyroid hormone-1 receptor down-regulation in kidneys from rats with chronic renal failure
    Edwards, RM
    Contino, LC
    Gellai, M
    Brooks, DP
    [J]. PHARMACOLOGY, 2001, 62 (04) : 243 - 247
  • [8] Fredholm BB, 2001, PHARMACOL REV, V53, P527
  • [9] Adenosine and hemodialysis in humans
    Guieu, R
    Brunet, P
    Sampol, J
    Bechis, G
    Fenouillet, E
    Mege, JL
    Capo, C
    Vitte, J
    Ibrahim, Z
    Carrega, L
    Lerda, D
    Rochat, H
    Berland, Y
    Dussol, B
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2001, 49 (01) : 56 - 67
  • [10] Adenosine A1 receptor antagonist improves intradialytic hypotension
    Imai, E
    Fujii, M
    Kohno, Y
    Kageyama, H
    Nakahara, K
    Hori, M
    Tsubakihara, Y
    [J]. KIDNEY INTERNATIONAL, 2006, 69 (05) : 877 - 883